+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression



Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression



Acta Psychiatrica Scandinavica. Supplementum 391: 22-30



A meta-analysis was performed on efficacy and safety data from 4 randomized, double-blind, 6-week, single-center studies comparing mirtazapine (n = 194; 5-35 mg/day) with amitriptyline (n = 193, 40-280 mg/day) and placebo (n = 193) in outpatients with a DSM-III diagnosis of major depressive episode. On all the main efficacy variables both active drugs consistently produced significantly greater improvements and significantly greater percentages of responders or remitters than placebo. The meta-analysis of adverse events shows that mirtazapine was better tolerated than amitriptyline, particularly with respect to anticholinergic and cardiac adverse events. There were no differences between mirtazapine and placebo regarding the incidence of serotonergic adverse events. In conclusion, the results of this meta-analysis demonstrate that mirtazapine is as effective as amitriptyline but has a better tolerability profile.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009011828

Download citation: RISBibTeXText

PMID: 9265948


Related references

Meta-analysis of randomized, double-blind, dacebo-controlled, efficacy and safety studies of mirtazapine versus amitripcyline in major depression. Acta Psychiatrica Scandinavica 96(Suppl. S391): 22-30, 1997

Meta-analysis of randomized, double-blind, placebo-controlled studies of mirtazapine vs amitriptyline. Biological Psychiatry 42(1): 247s-248s, 1997

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study. International Clinical Psychopharmacology 13(2): 63-73, 1998

A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. Journal of Clinical Psychiatry 59(3): 123-127, 1998

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies. Neuropsychiatric Disease and Treatment 12: 2859-2867, 2016

Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Current Medical Research and Opinion 29(11): 1539-1551, 2013

Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Psychiatry Research 228(1): 121-127, 2015

Antidepressant efficacy of sertraline a double blind placebo controlled and amitriptyline controlled multicenter comparison study in outpatients with major depression. Journal of Clinical Psychiatry 51(12 Suppl. B): 18-27, 1990

Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan. Pain 157(9): 2089-2096, 2016

Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. American Heart Journal 156(3): 437-444, 2008

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. Journal of Clinical Psychiatry 58(11): 484-491, 1997

A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression. Journal of Psychopharmacology 10(3): 235-240, 1996

Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. Journal of Clinical Psychiatry 51 Suppl B: 18-27, 1990

The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials. Epilepsy Research 120: 104-110, 2016

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials. Neuropsychiatric Disease and Treatment 14: 2519-2530, 2018